These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2466210)

  • 1. [Computed tomographic features of cerebral malignant glioma following treatment and regrowth. Growth patterns of recurrent tumors].
    Sato I; Tanaka R; Takeda N; Suzuki Y; Hondo H
    Neurol Med Chir (Tokyo); 1988 Nov; 28(11):1073-80. PubMed ID: 2466210
    [No Abstract]   [Full Text] [Related]  

  • 2. [Computed tomographic features of cerebral malignant glioma following treatment and regrowth. Tumor response to radiochemotherapy].
    Sato I; Tanaka R; Takeda N; Suzuki Y; Hondo H
    Neurol Med Chir (Tokyo); 1988 Nov; 28(11):1065-72. PubMed ID: 2466209
    [No Abstract]   [Full Text] [Related]  

  • 3. Management-Based Structured Reporting of Posttreatment Glioma Response With the Brain Tumor Reporting and Data System.
    Weinberg BD; Gore A; Shu HG; Olson JJ; Duszak R; Voloschin AD; Hoch MJ
    J Am Coll Radiol; 2018 May; 15(5):767-771. PubMed ID: 29503151
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of treatment results in glioma using computed tomography].
    Kruminia GA
    Zh Vopr Neirokhir Im N N Burdenko; 1988; (6):12-20. PubMed ID: 3239304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL12 and CXCR4 as predictive biomarkers of glioma recurrence pattern after total resection.
    Tang W; Wang X; Chen Y; Zhang J; Chen Y; Lin Z
    Pathol Biol (Paris); 2015 Sep; 63(4-5):190-8. PubMed ID: 26277915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-energy spectral CT quantitative parameters for the differentiation of Glioma recurrence from treatment-related changes: a preliminary study.
    Lv Y; Zhou J; Lv X; Tian L; He H; Liu Z; Wu Y; Han L; Sun M; Yang Y; Guo C; Li C; Zhang R; Xie C; Chen Y; Chen Z
    BMC Med Imaging; 2020 Jan; 20(1):5. PubMed ID: 31948400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regrowth patterns of glioma--cases of glioma regrew away from the original tumor].
    Kuratsu J; Itoyama Y; Uemura S; Ushio Y
    Gan No Rinsho; 1989 Sep; 35(11):1255-60. PubMed ID: 2681871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scintigraphic assessment of recurrent glioma with focus on proliferation.
    Alexiou GA; Tsiouris S; Polyzoidis KS; Kyritsis AP; Fotopoulos AD
    Nucl Med Commun; 2008 Sep; 29(9):840-1. PubMed ID: 18677216
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diagnosis and treatment of recurrent brain glioma].
    Pyrich M; Gościński I; Krzyszkowski T
    Neurol Neurochir Pol; 1992; Suppl 1():116-21. PubMed ID: 1407284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Status spongiosus in the course of treatment of malignant gliomas.
    Poisson M; Hauw JJ; Mashaly R; Duyckaerts C; Escourolle R
    J Neurooncol; 1983; 1(1):29-37. PubMed ID: 6678304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second temporal remission in a malignant glioma with trofosfamide and etoposide: a case report.
    Wolff JE; Boos J; Krähling KH; Jürgens H
    Klin Padiatr; 1996; 208(4):190-2. PubMed ID: 8776706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (18)F-Flourodeoxy-Glucose PET/Computed Tomography in Brain Tumors: Value to Patient Management and Survival Outcomes.
    Wray R; Solnes L; Mena E; Meoded A; Subramaniam RM
    PET Clin; 2015 Jul; 10(3):423-30. PubMed ID: 26099676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiology: criteria for determining response to treatment and recurrence of high-grade gliomas.
    Lucas J; Zada G
    Neurosurg Clin N Am; 2012 Apr; 23(2):269-76, viii. PubMed ID: 22440870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computed tomography of gliosarcoma.
    Lee YY; Castillo M; Nauert C; Moser RP
    AJNR Am J Neuroradiol; 1985; 6(4):527-31. PubMed ID: 3927668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superficial location of malignant glioma with heavily lipidized (foamy) tumor cells: a case report.
    Tanaka K; Waga S; Itho H; Shimizu DM; Namiki H
    J Neurooncol; 1989 Sep; 7(3):293-7. PubMed ID: 2795123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodality treatment of malignant gliomas. Comparison of several adjuvant approaches.
    Jellinger K; Volc D; Grisold W; Podreka I; Böck F; Schuster H; Alth G; Kogelnik HD
    Zentralbl Neurochir; 1981; 42(2-3):99-119. PubMed ID: 6267846
    [No Abstract]   [Full Text] [Related]  

  • 17. 11C-MET PET/CT and advanced MRI in the evaluation of tumor recurrence in high-grade gliomas.
    D'Souza MM; Sharma R; Jaimini A; Panwar P; Saw S; Kaur P; Mondal A; Mishra A; Tripathi RP
    Clin Nucl Med; 2014 Sep; 39(9):791-8. PubMed ID: 25036022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thallium-201 single-photon emission computed tomography as an early predictor of outcome in recurrent glioma.
    Vos MJ; Hoekstra OS; Barkhof F; Berkhof J; Heimans JJ; van Groeningen CJ; Vandertop WP; Slotman BJ; Postma TJ
    J Clin Oncol; 2003 Oct; 21(19):3559-65. PubMed ID: 12913097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivolumetric analysis of CT scans on patients with glioma.
    Riding MD; Gerig LH; Girard A; Stewart D
    Acta Radiol Suppl; 1986; 369():216-9. PubMed ID: 2980455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resection and reoperation in neuro-oncology. Rationale and approach.
    Salcman M
    Neurol Clin; 1985 Nov; 3(4):831-42. PubMed ID: 3908898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.